Cyclerion Therapeutics Inc
(CYCN)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
by (Cboe BZX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
[[ item.lastPriceExt ]]
[[ item.priceChangeExt ]]
([[ item.percentChangeExt ]])
[[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 09-2025 | 06-2025 | 03-2025 | 12-2024 | 09-2024 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -2,729 | -1,753 | -1,429 | -3,057 | -3,587 |
| Accounts receivable | 456 | 31 | -25 | -556 | N/A |
| Accounts payable and accrued liabilities | 90 | 72 | 93 | -445 | -531 |
| Other Working Capital | 648 | 54 | 347 | -1,538 | -1,246 |
| Other Operating Activity | -200 | 125 | 46 | 1,263 | 671 |
| Operating Cash Flow | $-1,735 | $-1,471 | $-968 | $-4,333 | $-4,693 |
| Cash Flows From Investing Activities | |||||
| Investing Cash Flow | $0 | $N/A | $N/A | $N/A | $0 |
| Cash Flows From Financing Activities | |||||
| Other Financing Activity | 3,071 | 1,245 | 1,375 | 0 | 0 |
| Financing Cash Flow | $3,071 | $1,245 | $1,375 | $N/A | $0 |
| Exchange Rate Effect | N/A | N/A | N/A | -6 | -6 |
| Beginning Cash Position | 3,232 | 3,232 | 3,232 | 7,571 | 7,571 |
| End Cash Position | 4,568 | 3,006 | 3,639 | 3,232 | 2,872 |
| Net Cash Flow | $1,336 | $-226 | $407 | $-4,339 | $-4,699 |
| Free Cash Flow | |||||
| Operating Cash Flow | -1,735 | -1,471 | -968 | -4,333 | -4,693 |
| Free Cash Flow | -1,735 | -1,471 | -968 | -4,333 | -4,693 |